We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.
Dave lost his twin brother to skin cancer at just 28. Here, Dave tells us Mark’s inspiring story through his cancer.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Read our final roundup from this year’s NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.
We step behind the microscope to look at research into shape-shifting cancer cells that’s funded by Stand Up To Cancer.
We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.
We explore the latest research from our scientists in Manchester that’s tracking how melanomas respond to treatment by analysing patient blood samples.
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a ‘targeted’ cancer drug.